When Cancer Spreads Beyond the Abdomen: A New Approach Offers Hope
- 2 days ago
- 2 min read
Ha, E., Suzuki, Y., Sarkaria, I.S. et al. Outcome Analysis of Cytoreductive Surgery and Hyperthermic Intrathoracic Chemoperfusion (HITHOC) for Pseudomyxoma Peritonei with Pleural Metastasis. Ann Surg Oncol 33, 3084–3090 (2026). https://doi.org/10.1245/s10434-025-18880-8
What is this study about?
This study looked at a rare but challenging situation: when a condition called pseudomyxoma peritonei (PMP)—a cancer that usually starts in the abdomen—spreads to the chest (pleura).
Because this type of spread is uncommon, doctors are still learning the best way to treat it. This research explored whether combining surgery with a specialized heated chemotherapy treatment in the chest could improve outcomes.
What treatments were studied?
Patients in this study received a combination of treatments:
Cytoreductive surgery (CRS): Surgery to remove as much visible cancer as possible
HIPEC: Heated chemotherapy delivered into the abdomen
HITHOC: Heated chemotherapy delivered into the chest (a newer approach)
HITHOC is similar to HIPEC but is used in the chest cavity instead of the abdomen.
Why is this important?
PMP typically stays in the abdomen, but in some cases it spreads to the chest. When this happens:
It becomes much harder to treat
There are fewer established treatment options
Patients may have limited choices
This study looks at whether adding targeted treatment in the chest can help control the disease.
What did the researchers do?
Researchers reviewed outcomes from over 800 patients treated for PMP:
About 8% developed cancer spread to the chest
Some patients received the additional chest treatment (HITHOC)
Others did not
They then compared how long patients lived and how their disease progressed.
What were the results?
Patients who received the chest treatment lived longer after the cancer spread to the chest
They also had longer overall survival from their original treatment
The procedure appeared safe, with no deaths shortly after surgery in this group
What does this mean for patients?
This research suggests that:
Treating cancer directly in the chest with heated chemotherapy may improve outcomes
A combined approach (surgery + targeted chemotherapy) could offer new hope for a difficult-to-treat situation
This strategy may be useful both to extend survival and improve quality of life
However, this is still an emerging approach, and more research is needed.
Key takeaways
Some abdominal cancers can spread to the chest, creating new treatment challenges
A newer technique (HITHOC) delivers chemotherapy directly where cancer has spread
Early results suggest it may help patients live longer
